-
Hong Kong arrests two for allegedly selling 'seditious' material
-
Laporte wary of Uruguay will to avoid World Cup exit against Spain
-
US promises to protect Gulf states' interests in Iran talks
-
Major Nigeria police reform edges forward with senate approval
-
Trials of two Ebola treatments to start in DRC next week: WHO
-
Trump consolidates rightward shift in Latin America
-
Judge asks why Kennedy Center covering facade after Trump's name removed
-
Olympics to offer all Games competitors $10,000 grants
-
Germany sinks troubled warship project in blow to naval ambitions
-
Left-wing candidate concedes tight Colombia election
-
US health deals cause trouble for Kenya govt
-
Stocks rebound after tech rout, Brent falls below $75
-
Socialism with a twist or crony capitalism? Cuban reforms spark debate
-
Berlin unveils monument to Jehovah's Witnesses murdered by Nazis
-
'Inhumane': Gaza flotilla activists recount Israeli detention ordeal
-
'Fingerprints' of black hole's event horizon detected for first time
-
Spurs sign Dubravka as goalkeeper cover
-
Verstappen seeking home boost with Red Bull upgrades
-
Stocks steady after tech rout, Brent falls below $75
-
'You have to work': Riders brave Rome heat for survival
-
England captain Stokes 'man enough' to apologise for curfew breach
-
France detects first Ebola case outside Africa in current outbreak
-
England captain Stokes 'man enough' to apologise after curfew breach
-
'GTA VI' preorders mark first test for biggest game of 2026
-
German naval ambitions suffer setback as warship order axed
-
Stocks rebound after tech rout, oil prices drop
-
London police to extend use of live facial recognition, drones
-
Australia spy chief warns of Iran terror threat
-
Europe swelters under record-breaking heatwave
-
Heatwave-hit Europe must adapt healthcare: WHO
-
Iran says deal to end Mideast war 'declaration of US defeat'
-
Euclid telescope snaps best photo yet of Milky Way's heart
-
S.Korea chip giant SK hynix seeks $29 bn in Nasdaq listing: regulatory filing
-
French-German tank maker KNDS fires starting gun on mega-IPO
-
'Pragmatists' vs 'hardliners': Is Iran split over US deal?
-
Right-winger Fujimori poised to win Peru president runoff
-
H5 bird flu detected in second Australia state
-
Major power outage in France as Europe wilts under record heat
-
Brazil aim for last 32 as World Cup goes into hectic phase
-
Back in stork: returning birds bring joy to Croatian village
-
Necessity drives gold miners in DR Congo's Ebola epicentre
-
China premier urges AI governance to avoid 'losing control'
-
Japan PM heckled at WWII memorial
-
Colombia beat DR Congo 1-0 to reach World Cup knockouts
-
Hanoi residents mount silent protest over home demolitions
-
West Indies brace for Sri Lanka challenge as Da Silva returns
-
US Congress passes symbolic Iran war rebuke to Trump
-
Stokes urged to use curfew controversy as fuel to beat New Zealand
-
Bolivia's government is 'stoking a civil war,' ex-president Evo Morales tells AFP
-
Seoul bounces as Asian markets look to recover from rout
Philips chops back US tariff bill
Dutch medical equipment manufacturer Philips said Tuesday that the impact of US tariffs would be much less than it initially estimated, sending its share price surging.
The company had originally estimated in April that US tariffs could cost it 250 to 300 million euros this year after President Donald Trump unveiled a 20 percent tariff rate for goods from the European Union.
Brussels and Washington reached a deal over the weekend that will see goods from the EU face a baseline 15 percent levy when imported into the United States.
It said Tuesday it now expects between 150 and 200 million euros impact from US tariffs this year.
Chief executive Roy Jakobs said Philips updated "the guidance because we have certainty now around what is happening between the EU and the US."
Shares in Philips jumped more than 10 percent during morning trading, while the Amsterdam market rose around 0.4 percent overall.
The trade deal has come under widespread criticism in Europe as having been lopsided, saddling its manufacturers with a costly 15 percent rate with little in return from the US as certainty is a relative concept given Trump's propensity to change positions.
Jakobs said that certainty "is what we value in" in the deal, while acknowledging "it's a painful additional cost we have to carry".
The company still targets a one to three percent increase in annual sales.
Second quarter net profit fell by 47 percent to 240 million euros, but last year's performance was boosted by exceptional income from insurance payouts linked to long-running issues with its sleep apnoea machines.
Sales slid by 2.8 percent to 4.3 billion euros, although they edged higher on a comparable basis that excludes currency changes. The company also noted orders rose by six percent on a comparable basis.
The appreciation of the euro relative to the dollar and other currencies has been crimping the results of European companies as their revenues abroad result in fewer euros on the balance sheet.
Long known for its light bulbs and television sets, the Dutch company has refocused its business towards medical equipment.
L.Maurer--VB